278 related articles for article (PubMed ID: 11044112)
1. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.
Scholle F; Bendt KM; Raab-Traub N
J Virol; 2000 Nov; 74(22):10681-9. PubMed ID: 11044112
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.
Fukuda M; Longnecker R
J Virol; 2007 Sep; 81(17):9299-306. PubMed ID: 17582000
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
Morrison JA; Klingelhutz AJ; Raab-Traub N
J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
Fotheringham JA; Coalson NE; Raab-Traub N
J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
Swart R; Ruf IK; Sample J; Longnecker R
J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
[TBL] [Abstract][Full Text] [Related]
7. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.
Fukuda M; Longnecker R
J Virol; 2004 Feb; 78(4):1697-705. PubMed ID: 14747535
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.
Kong QL; Hu LJ; Cao JY; Huang YJ; Xu LH; Liang Y; Xiong D; Guan S; Guo BH; Mai HQ; Chen QY; Zhang X; Li MZ; Shao JY; Qian CN; Xia YF; Song LB; Zeng YX; Zeng MS
PLoS Pathog; 2010 Jun; 6(6):e1000940. PubMed ID: 20532215
[TBL] [Abstract][Full Text] [Related]
9. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.
Matskova LV; Helmstetter C; Ingham RJ; Gish G; Lindholm CK; Ernberg I; Pawson T; Winberg G
Oncogene; 2007 Jul; 26(34):4908-17. PubMed ID: 17311000
[TBL] [Abstract][Full Text] [Related]
10. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling.
Morrison JA; Raab-Traub N
J Virol; 2005 Feb; 79(4):2375-82. PubMed ID: 15681438
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
Chen SY; Lu J; Shih YC; Tsai CH
J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling.
Dawson CW; Tramountanis G; Eliopoulos AG; Young LS
J Biol Chem; 2003 Feb; 278(6):3694-704. PubMed ID: 12446712
[TBL] [Abstract][Full Text] [Related]
13. Rhesus lymphocryptovirus latent membrane protein 2A activates beta-catenin signaling and inhibits differentiation in epithelial cells.
Siler CA; Raab-Traub N
Virology; 2008 Aug; 377(2):273-9. PubMed ID: 18570966
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.
Allen MD; Young LS; Dawson CW
J Virol; 2005 Feb; 79(3):1789-802. PubMed ID: 15650203
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.
Moody CA; Scott RS; Amirghahari N; Nathan CO; Young LS; Dawson CW; Sixbey JW
J Virol; 2005 May; 79(9):5499-506. PubMed ID: 15827164
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
18. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
[TBL] [Abstract][Full Text] [Related]
19. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation.
Fukuda M; Kawaguchi Y
J Virol; 2014 May; 88(9):5189-94. PubMed ID: 24554661
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells.
Nakaya T; Kikuchi Y; Kunita A; Ishikawa S; Matsusaka K; Hino R; Aburatani H; Fukayama M
Virus Res; 2013 Jun; 174(1-2):108-15. PubMed ID: 23524324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
